BR0307893A - Formulação oftálmica com sistema de goma - Google Patents
Formulação oftálmica com sistema de gomaInfo
- Publication number
- BR0307893A BR0307893A BR0307893-0A BR0307893A BR0307893A BR 0307893 A BR0307893 A BR 0307893A BR 0307893 A BR0307893 A BR 0307893A BR 0307893 A BR0307893 A BR 0307893A
- Authority
- BR
- Brazil
- Prior art keywords
- ophthalmic formulation
- gum system
- gum
- eye
- active agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"FORMULAçãO OFTáLMICA COM SISTEMA DE GOMA". A presente invenção refere-se a uma composição farmacêutica adequada para a administração tópica a um olho, a composição compreendendo (a) uma concentração farmacologicamente eficaz de um agente ativo; e (b) um conjunto de pelo menos dois polímeros oftalmicamente compatíveis compreendendo um novo sistema de goma. Em modalidades preferidas da presente invenção, as composições aumentam o tempo de retenção do agente ativo no olho, quando em comparação com as composições com outras gomas ou sistemas de gomas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35876102P | 2002-02-22 | 2002-02-22 | |
PCT/US2003/005361 WO2003072081A1 (en) | 2002-02-22 | 2003-02-20 | Ophthalmic formulation with gum system |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0307893A true BR0307893A (pt) | 2004-12-07 |
Family
ID=27765988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0307893-0A BR0307893A (pt) | 2002-02-22 | 2003-02-20 | Formulação oftálmica com sistema de goma |
Country Status (10)
Country | Link |
---|---|
US (1) | US7128928B2 (pt) |
EP (1) | EP1476135A1 (pt) |
JP (1) | JP2005521690A (pt) |
AR (1) | AR038575A1 (pt) |
AU (1) | AU2003213210A1 (pt) |
BR (1) | BR0307893A (pt) |
CA (1) | CA2477044A1 (pt) |
MX (1) | MXPA04008171A (pt) |
TW (1) | TW200400055A (pt) |
WO (1) | WO2003072081A1 (pt) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20090215735A1 (en) * | 2002-02-25 | 2009-08-27 | Alcon, Inc. | Topical solution formulations containing a corticosteroid and a cyclodextrin |
TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
KR101147046B1 (ko) * | 2003-06-13 | 2012-05-22 | 알콘, 인코퍼레이티드 | 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물 |
US7914803B2 (en) * | 2003-06-13 | 2011-03-29 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of three polymers |
US6933289B2 (en) * | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
JP2006528190A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
CA2533178C (en) | 2003-07-21 | 2014-03-11 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US8425936B2 (en) | 2003-07-21 | 2013-04-23 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
CA2535177A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
US8062672B2 (en) | 2003-08-12 | 2011-11-22 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
AU2004270170B2 (en) | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
JP2007513952A (ja) * | 2003-12-11 | 2007-05-31 | アルコン、インコーポレイテッド | 多糖/ホウ酸塩ゲル化系を含む眼用組成物 |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
CN1921833A (zh) * | 2004-02-26 | 2007-02-28 | 博士伦公司 | 藻酸盐粘弹性组合物、使用方法及包装 |
PT1767219E (pt) * | 2004-03-10 | 2010-02-15 | Shimoda Biotech Pty Ltd | Composições injectáveis estáveis de diclofenac |
EP2127655A1 (en) * | 2004-03-25 | 2009-12-02 | Bausch & Lomb Incorporated | Use of loteprednol etabonate for the treatment of dry eye |
US20050215516A1 (en) * | 2004-03-29 | 2005-09-29 | Claudio Bucolo | New free-radical scavenger containing viscoelastic composition, methods of use and package |
AU2005269981A1 (en) | 2004-07-02 | 2006-02-09 | Bonck, John A | Tablet for pulsed delivery |
WO2006038080A2 (en) * | 2004-10-01 | 2006-04-13 | Clearlab International Pte. Ltd. | Contact lens package solution |
US20060134060A1 (en) * | 2004-12-22 | 2006-06-22 | Erning Xia | Ophthalmic compositions comprising Aloe Vera |
DE602006010702D1 (de) | 2005-06-29 | 2010-01-07 | Pharmacia & Upjohn Co Llc | Homomorpholinoxazolidinone als antibakterielle mittel |
US20070004672A1 (en) * | 2005-07-01 | 2007-01-04 | Dharmendra Jani | Long lasting alginate dry eye, related methods of manufacture and methods of use |
US8067433B2 (en) | 2005-11-09 | 2011-11-29 | Zalicus Inc. | Methods, compositions, and kits for the treatment of ophthalmic disorders |
US20070110812A1 (en) * | 2005-11-14 | 2007-05-17 | Bausch & Lomb Incorporated | Ophthalmic composition for dry eye therapy |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
CA2636646A1 (en) * | 2006-01-25 | 2007-08-02 | Aciex, Inc. | Formulations and methods for treating dry eye |
US20090010850A1 (en) * | 2007-05-24 | 2009-01-08 | Ousler Iii George W | Formulations and methods for treating dry eye |
US20100130580A1 (en) * | 2006-01-25 | 2010-05-27 | Aciex Therapeutics, Inc. | Formulations and Methods for Treating Dry Eye |
CN101410123A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的双氯芬酸和β-环糊精的制剂 |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2008088612A1 (en) * | 2006-12-20 | 2008-07-24 | Bausch & Lomb Incorporated | Method of stimulating the production of mucin in the eye of a patient |
US7659259B2 (en) * | 2006-12-21 | 2010-02-09 | Bausch & Lomb Incorporated | Method of treating inflammation of the eye |
WO2008082948A2 (en) * | 2006-12-29 | 2008-07-10 | Bausch & Lomb Incorporated | Ophthalmic alginate composition related methods of manufacture and methods of use |
ES2460570T3 (es) * | 2007-02-09 | 2014-05-13 | Novartis Ag | Composiciones oftálmicas que contienen una combinación sinérgica de tres polímeros |
WO2008137496A1 (en) * | 2007-05-04 | 2008-11-13 | Bausch & Lomb Incorporated | Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
CN101754745A (zh) * | 2007-05-07 | 2010-06-23 | 博士伦公司 | 用于缓解、改善、治疗或预防干眼症的组合物及其制备和使用方法 |
ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
US20110046033A1 (en) * | 2008-01-31 | 2011-02-24 | Jinzhong Zhang | Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function |
US9096819B2 (en) | 2008-01-31 | 2015-08-04 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer |
US9481856B2 (en) * | 2008-06-09 | 2016-11-01 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
KR20110042282A (ko) * | 2008-06-12 | 2011-04-26 | 노파르티스 아게 | 눈 전면에 대한 지속 전달제로서의 인 시츄 겔화 시스템 |
CN102209548A (zh) * | 2008-09-15 | 2011-10-05 | 博士伦公司 | 包含具有氨基糖单元的聚合物的组合物及其制备和使用方法 |
US20100087550A1 (en) | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
WO2010118340A1 (en) * | 2009-04-09 | 2010-10-14 | University Of Medicine And Dentistry Of New Jersey | Treatment of cutaneous hemangioma |
KR101809484B1 (ko) | 2009-12-03 | 2017-12-15 | 알콘 리서치, 리미티드 | 카복시비닐 폴리머를 포함하는 나노입자 현탁액 |
US20130165419A1 (en) * | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
TW201336527A (zh) * | 2012-02-10 | 2013-09-16 | Alcon Res Ltd | 具增強的穩定性之水性藥學組成物 |
JP6207291B2 (ja) * | 2013-08-07 | 2017-10-04 | 大同化成工業株式会社 | 外用剤用組成物 |
US10052313B2 (en) * | 2013-08-28 | 2018-08-21 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
US10959990B2 (en) * | 2013-08-28 | 2021-03-30 | Presbyopia Therapies, Inc | Compositions and methods for the treatment of presbyopia |
US10350232B1 (en) | 2013-11-04 | 2019-07-16 | Peter D. Jaillet | Medicinal drops |
WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
CN107847604B (zh) | 2015-10-25 | 2020-11-10 | 艾威药业(珠海)有限公司 | 眼用原位凝胶处方 |
US20210251970A1 (en) | 2018-10-10 | 2021-08-19 | Presbyopia Therapies Inc | Compositions and methods for storage stable ophthalmic drugs |
US11648247B1 (en) | 2021-12-16 | 2023-05-16 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136178A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Locust bean gum therapeutic compositions |
US4136173A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
SE8305864D0 (sv) * | 1983-10-25 | 1983-10-25 | L E Medical | Ogondroppar |
DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US4676976A (en) * | 1985-03-08 | 1987-06-30 | Ajinomoto Co., Inc. | Konjak mannan-containing reversible gel |
FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
DE3704907A1 (de) | 1987-02-17 | 1988-08-25 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5135920A (en) | 1988-11-16 | 1992-08-04 | Takeda Chemical Industries, Ltd. | Angiostatic agents |
US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
FR2653021A1 (fr) | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5369095A (en) | 1990-02-14 | 1994-11-29 | Alcon Laboratories, Inc. | Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers |
US5227372A (en) | 1990-03-07 | 1993-07-13 | Children's Medical Center Corporation | Method for retaining ophthalmological agents in ocular tissues |
DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
WO1993017664A1 (en) | 1992-03-02 | 1993-09-16 | Alcon Laboratories, Inc. | Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
IL105553A (en) | 1992-05-06 | 1998-01-04 | Janssen Pharmaceutica Inc | Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water |
NO304832B1 (no) | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
US5358706A (en) | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
JPH06345653A (ja) | 1993-06-08 | 1994-12-20 | Asahi Chem Ind Co Ltd | 点眼液 |
US5631004A (en) | 1993-09-30 | 1997-05-20 | Alcon Laboratories, Inc. | Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
SE9401108D0 (sv) | 1994-03-31 | 1994-03-31 | Leiras Oy | Ophthalmic composition I |
SE9401109D0 (sv) | 1994-03-31 | 1994-03-31 | Leiras Oy | Opthalmic composition II |
IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
TW434023B (en) | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
WO1997028827A1 (fr) | 1996-02-07 | 1997-08-14 | Rohto Pharmaceutical Co., Ltd. | Composition ophtalmique possedant une viscosite adaptee |
CZ298060B6 (cs) | 1996-04-11 | 2007-06-06 | Pharmacia & Upjohn Company | Zpusob prípravy oxazolidinonu |
HU225819B1 (en) | 1996-06-17 | 2007-10-29 | Janssen Pharmaceutica Nv | Biconvex rapidly disintegrating dosage forms |
US5888493A (en) | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
GB9707934D0 (en) | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
US5874418A (en) | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
US6046177A (en) | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
PT986403E (pt) | 1997-06-13 | 2004-04-30 | Cydex Inc | Composicao com um tempo de vida de armazenagem prolongado compreendendo a ciclodextrina e drogas ou prodrogas que se decompoem em compostos insoluveis em agua |
GB9714102D0 (en) * | 1997-07-04 | 1997-09-10 | Ciba Geigy Ag | Compounds |
JP3979783B2 (ja) * | 1997-07-29 | 2007-09-19 | アルコン ラボラトリーズ インコーポレイテッド | ガラクトマンナンポリマー及びホウ酸塩を含む眼科組成物 |
EP1028940B1 (en) | 1997-11-07 | 2007-04-18 | Pharmacia & Upjohn Company LLC | Process to produce oxazolidinones |
AU2798299A (en) | 1998-02-27 | 1999-09-15 | Althexis Company, The | Therapeutic and prophylactic uses of negatively charged substituted disaccharides |
US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
CA2373979A1 (en) | 1999-07-06 | 2001-01-11 | George Endel Deckner | Pre-formed gel sheet |
JP2003529544A (ja) | 1999-09-13 | 2003-10-07 | インサイト・ビジョン・インコーポレイテッド | 眼感染症の予防たのための局所処置 |
GB2363386B (en) | 2000-06-16 | 2004-07-28 | Chesham Chemicals Ltd | Fluid gel comprising xanthan and non-gelling polysaccharides |
AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
-
2003
- 2003-02-20 AR ARP030100557A patent/AR038575A1/es unknown
- 2003-02-20 US US10/370,220 patent/US7128928B2/en not_active Expired - Fee Related
- 2003-02-20 WO PCT/US2003/005361 patent/WO2003072081A1/en active Application Filing
- 2003-02-20 AU AU2003213210A patent/AU2003213210A1/en not_active Abandoned
- 2003-02-20 BR BR0307893-0A patent/BR0307893A/pt not_active IP Right Cessation
- 2003-02-20 JP JP2003570827A patent/JP2005521690A/ja not_active Withdrawn
- 2003-02-20 CA CA002477044A patent/CA2477044A1/en not_active Abandoned
- 2003-02-20 MX MXPA04008171A patent/MXPA04008171A/es not_active Application Discontinuation
- 2003-02-20 EP EP03709256A patent/EP1476135A1/en not_active Withdrawn
- 2003-02-20 TW TW092103511A patent/TW200400055A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US7128928B2 (en) | 2006-10-31 |
TW200400055A (en) | 2004-01-01 |
JP2005521690A (ja) | 2005-07-21 |
AU2003213210A1 (en) | 2003-09-09 |
EP1476135A1 (en) | 2004-11-17 |
WO2003072081A1 (en) | 2003-09-04 |
US20030232089A1 (en) | 2003-12-18 |
MXPA04008171A (es) | 2004-11-26 |
CA2477044A1 (en) | 2003-09-04 |
AR038575A1 (es) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
BR0212475A (pt) | Composições farmacêuticas | |
BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
BR0207930A (pt) | Composições farmacêuticas lìquidas com sabor mascarado | |
BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
ES2172242T3 (es) | Composiciones oftalmicas de liberacion mantenida conteniendo medicamentos solubles en agua. | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
BR0108173A (pt) | Composições farmacêuticas de toxina de botulina | |
BR122012030846B8 (pt) | composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma | |
BRPI0414876A (pt) | compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos | |
BR9810320A (pt) | Composição farmacêutica sólida, contendo derivados de benzofurano | |
BR0210139A (pt) | Composições farmacêuticas | |
MXPA05001061A (es) | Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol. | |
BR0116186A (pt) | Sistema de gelificação reversìvel para liberação de droga ocular | |
BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
FR2718963B1 (fr) | Nouvelle composition pharmaceutique à base de taxoïdes. | |
BR0015256A (pt) | Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano | |
BR0012696A (pt) | Composição oftálmica | |
SE9300581D0 (sv) | Komposition foer nasalbehandling | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
BR0313428A (pt) | Composições farmacêuticas de drogas semi-ordenados e polìmeros | |
ES2168457T3 (es) | Composiciones farmaceuticas que comprenden una superoxido dismutasa. | |
BR0309057A (pt) | Formulações lìquidas com baixa dosagem em entecavir e uso | |
BRPI0412364A (pt) | composição farmacêutica sólida, compreendendo amisulpride | |
ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A. E 7A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |